1-20 of 24
Anna G Turkina, Prof., MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs

Free
Andreas Hochhaus, MD, Carla Boquimpani, MD, Delphine Rea, MDPhD, Yosuke Minami, MDPhD, Elza Lomaia, MD PhD, Sergey Voloshin, MD PhD, Anna G. Turkina, Prof., MD, Dong-Wook Kim, MD, Jane Apperley, FRCP, FRCPath, MB, Jorge E. Cortes, MD, Andre Abdo, MD, Laura Maria Fogliatto, MD PhD, Dennis Dong Hwan Kim, MD PhD, Philipp D le Coutre, MD, Susanne Saussele, MD, Mario Annunziata, MD, Timothy P. Hughes, MDMBBS,FRACP,FRCPA, Naeem A. Chaudhri, MD, Lynette C.Y. Chee, MBBS,PhDFRACP,FRCPA, Valentín García Gutiérrez, MD PhD, Koji Sasaki, MD, Paola Aimone, MD, Alex Allepuz, MD MPH, Sarah Quenet, Véronique Bédoucha, Michael J. Mauro, MD
Journal: Blood
Blood (2020) 136 (Supplement_2): LBA-4.
https://doi.org/10.1182/blood-2020-143816
Published: 2020
Journal Articles

The Role of BCR-ABL Levels Fluctuations and Loss of Deep Molecular Response after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia in the Prospective Trial RU-SKI

Free
Anna Petrova, MD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anastasiya Bykova, MD, Irina Nemchenko, MD PhD, Olga Pospelova, MD, Margarita Gurianova, MD, Nikolay Tsyba, MD PhD, Tatiana I. Ionova, Prof., Anna G. Turkina, Prof., MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-141798
Published: 2020
Journal Articles

ENESTop 5-Year Update: Durability of Treatment-Free Remission Following Second-Line Nilotinib and Exploratory Analysis of Molecular Response Regain after Nilotinib Re-Initiation in Patients with Chronic Myeloid Leukemia

Free
Francois-Xavier Mahon, MD PhD, Nelma D Clementino, MD, Mikhail Fominykh, MD, Jeffrey H. Lipton, MD PhD, Anna G. Turkina, Prof., MD, Beatriz Moiraghi, MD, Franck E Nicolini, MDPhD, Naoto Takahashi, MD PhD, Tomasz Sacha, MDPhD, Dong-Wook Kim, MD, Rafik Fellague-Chebra, MD, Ranjan Tiwari, MSc, Catherine Bouard, Timothy P. Hughes, MDMBBS,FRACP,FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-136250
Published: 2020
Journal Articles

The Impact of Comorbidity on Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Results of the RU-SKI Trial

Free
Tatyana Ionova, PhD Professor, Tatiana Nikitina, PhD, Natalia Porfirieva, Anna Petrova, MD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anastasiya Bykova, MD, Galina Gusarova, MD PhD, Irina Nemchenko, MD PhD, Nikolay Tsyba, MD PhD, Anna G. Turkina, Prof., MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2925.
https://doi.org/10.1182/blood-2019-122041
Published: 2019
Journal Articles

PF-114: A 4 th Generation Tyrosine Kinase-Inhibitor for Chronic Phase Chronic Myeloid Leukaemia Including BCRABL1 T315I

Free
Anna G. Turkina, Prof., MD, Olga Vinogradova, MD PhD, Elza Lomaia, MD PhD, Evgeniya Shatokhina, MD PhD, Oleg A. Shukhov, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Dzhariyat Shikhbabaeva, Irina Nemchenko, MD PhD, Anna Petrova, MD, Anastasiya Bykova, MD, Andrey Zaritskey, MD PhD, Nadia Siordia, MD, Vasily Shuvaev, MD, Jorge E. Cortes, MD, Robert Peter Gale, Michele Baccarani, MD, Oliver Ottmann, Prof, MD, Ilya Mikhailov, Fedor Novikov, PhD, Veronika Shulgina, PhD MD, Ghermes Chilov, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1638.
https://doi.org/10.1182/blood-2019-127951
Published: 2019
Journal Articles

Changes in the Multipotent Stromal Mesenchymal Cells from the Bone Marrow of the Patients with Hematological Diseases in Debut and after the Treatment

Free
Irina N. Shipounova, PhD, Nataliya A. Petinati, MD PhD, Nina J. Drize, PhD, Aminat A. Magomedova, MD PhD, Ekaterina A. Fastova, MD, Sergey K. Kravchenko, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anna G. Turkina, Prof., MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician
Journal: Blood
Blood (2019) 134 (Supplement_1): 5014.
https://doi.org/10.1182/blood-2019-123396
Published: 2019
Journal Articles

Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database

Free
Elisabetta Abruzzese, MD, Anna G. Turkina, Prof., MD, Jane F. Apperley, MD FRCP, FRCPath, MB, Francesco Bondanini, MD, Paolo de Fabritiis, MD, Dong-Wook Kim, Iryna Dyagil, MD PhD, Penka Ganeva, Valentín Garcia-Gutiérrez, MD PhD, Khamida Kazakbaeva, MD, Hana Klamová, MD PhD, Konstantin Kotlyarchuk, Michael J. Mauro, MD, Dragana Milojkovic, MBBS, MD, Beatriz Moriaghi, MD, Karen Meliktesyan, MD, Franck E Nicolini, MD PhD, Evgenia Polushkina, Delphine Rea, MD, Philippe Rousselot, MD PhD, Adi Shacham, MD, Roman Shmakov, MD PhD, Malgorzata Monika Trawinska, MD, Ekaterina Yu. Chelysheva, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 498.
https://doi.org/10.1182/blood-2019-124430
Published: 2019
Journal Articles

On a Long Way to the Treatment Free Remisson: The Results of the Long-Term Observation of the Chronic Myeloid Leukemia Patients in Russian Part of EUTOS Population-Based Study

Free
Olga V. Lazareva, PhD, Ekaterina Yu. Chelysheva, MD PhD, Anton Kulikovsky, Olga Senderova, Valentina Pepeliaeva, Sergey Meresiy, Alexander S. Luchinin, MD, Galina Milutina, Lubov Gavrilova, Ludmila Avdeeva, Dolgorzhap Dasheeva, Olga Vinogradova, MD PhD, Sergei M. Kulikov, PhD, Anna G. Turkina, Prof., MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5902.
https://doi.org/10.1182/blood-2019-131430
Published: 2019
Journal Articles

Phase-1 Study of PF-114 Mesylate in CML Failing Prior Tyrosine Kinase-Inhibitor Therapy

Free
Anna G Turkina, Prof., MD, Olga Vinogradova, MD PhD, Elza Lomaia, MD, Evgeniya Shatokhina, MD PhD, Oleg Shukhov, MD PhD, Ekaterina Chelysheva, MD PhD, Irina Nemchenko, MD PhD, Anna Petrova, MD, Anastasiya Bykova, MD, Andrey Zaritskey, MD PhD, Nadia Siordia, MD, Dzhariyat Shikhbabaeva, Vasily Shuvaev, MD, Jorge E. Cortes, MD, Robert Peter Gale, Michele Baccarani, MD, Oliver G. Ottmann, MD, Ilya Mikhailov, Fedor Novikov, PhD, Veronika Shulgina, PhD MD, Ghermes Chilov, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 790.
https://doi.org/10.1182/blood-2018-99-116803
Published: 2018
Journal Articles

Kinetics of the Leukemic Clone in Patients with Chronic Myeloid Leukemia during Pregnancy

Free
Ekaterina Chelysheva, MD PhD, Jane Apperley, MB ChB MD, Elisabetta Abruzzese, Dong-Wook Kim, MD PhD, Konstantin Kotlyarchuk, Oleg Shukhov, MD PhD, Anna G Turkina, Prof., MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4254.
https://doi.org/10.1182/blood-2018-99-115984
Published: 2018
Journal Articles

Chronic Myeloid Leukemia Diagnosed during Pregnancy: Therapy, Outcomes and Follow-up

Free
Ekaterina Chelysheva, MD PhD, Elisabetta Abruzzese, Delphine Rea, MD, Dong-Wook Kim, MD PhD, Khamida Kazakbaeva, MD, Sukhrob Saliev, Konstantin Kotlyarchuk, Evgenia Polushkina, Roman Shmakov, MD PhD, Julia Chabaeva, Sergei M. Kulikov, PhD, Anna G Turkina, Prof., MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4255.
https://doi.org/10.1182/blood-2018-99-115983
Published: 2018
Journal Articles

Social Parameters Are Independent Predictors for Survival in Chronic Myeloid Leukemia

Free
Sergei M. Kulikov, PhD, Anna G Turkina, Prof., MD, Anton Kulikovsky, Olga Lazareva, PhD, Sergey Kutsev, Prof., MD, PhD, Elza Lomaia, MD, Andrey Zaritskey, MD PhD, Anatoly Golenkov, MDProf, Tatiana Pospelova, MD PhD, Satokhin Yuri, MD PhD, Tatiana Konstantinova, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1735.
https://doi.org/10.1182/blood-2018-99-114700
Published: 2018
Journal Articles

Prognostic Model of Successful Tyrosine Kinase Inhibitors Discontinuation Based on the Russian RU-SKI Multicenter Prospective Study

Free
Oleg Shukhov, MD PhD, Ekaterina Chelysheva, MD PhD, Anna Petrova, MD, Anastasiya Bykova, MD, Irina Nemchenko, MD PhD, Galina Gusarova, MD PhD, Eduard Gemdzhian, Anna G Turkina, Prof., MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1740.
https://doi.org/10.1182/blood-2018-99-116321
Published: 2018
Journal Articles

Analysis of the Effectiveness of Maintenance Therapy By Imatinib in Patients with Pdgfra -Positive Neoplasm

Free
Irina Nemchenko, MD PhD, Nikolay Tsyba, MD PhD, Ekaterina Chelysheva, MD PhD, Oleg Shukhov, MD PhD, Anna G Turkina, Prof., MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1755.
https://doi.org/10.1182/blood-2018-99-116262
Published: 2018
Journal Articles

Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Interim Results of Russian Prospective Multicenter Trial RU-SKI

Free
Anna Petrova, MD, Ekaterina Chelysheva, MD PhD, Oleg Shukhov, MD PhD, Anastasiya Bykova, MD, Galina Gusarova, MD PhD, Irina Nemchenko, MD PhD, Nikolay Tsyba, MD PhD, Anna G Turkina, Prof., MD, Tatiana Nikitina, PhD, Natalia Porfirieva, Anna Zinkovskaya, Tatiana Ionova, DSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3023.
https://doi.org/10.1182/blood-2018-99-113360
Published: 2018
Journal Articles

PF-114 Mesylate, a Novel Third Generation ATP-Competitive BCR-ABL Tyrosine Kinase Inhibitor: First Safety and Efficacy Data from a Phase I Study in Patients with CML with Failure of Prior TKI Therapy

Free
Anna G Turkina, Prof., MD, Oleg Shukhov, MDPhD, Ekaterina Chelysheva, MDPhD, Irina Nemchenko, MD PhD, Anna Petrova, MD, Anastasiya Bykova, MD, Andrey Zaritskey, Elza Lomaia, MD, Vasily Shuvaev, MD PhD, Fedor Novikov, PhD, Veronika Shulgina, PhD MD, Ghermes Chilov, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 895.
https://doi.org/10.1182/blood.V130.Suppl_1.895.895
Published: 2017
Journal Articles

Dynamics of Gene Expression of Surface Receptors of Apoptosis in Primary Patients with B-CLL during Induction Treatment

Free
Sergei Zakharov, Anatoly Golenkov, MDProf, Vsevolod A. Misyurin, PhD, Elena Kataeva, MD, Andrey Misyurin, PhD, Tatiana Mitina, MD, Baryshnikova Maria, PhD, Elena Trifonova, MD PhD, Yulia Chernykh, Ludmila Vysotskaya, PhD, Elena Klinushkina, Anna G Turkina, Prof., MD, Kirill Belousov
Journal: Blood
Blood (2017) 130 (Supplement 1): 4970.
https://doi.org/10.1182/blood.V130.Suppl_1.4970.4970
Published: 2017
Journal Articles

Second-Line Bosutinib in Patients with Chronic Phase Chronic Myeloid Leukemia (CP CML) Resistant or Intolerant to Prior Imatinib: An 8-Year Update

Free
Tim H. Brümmendorf, MD, Carlo Gambacorti-Passerini, MD, Dong-Wook Kim, MD PhD, Yeow Tee Goh, MBBS,MD, Iryna Dyagil, MDPhD, Katia B Pagnano, MD, Árpád Bátai, MD, Anna G Turkina, Prof., MD, Jean M. Aguiar, RN, Eric Leip, PhD, Jorge E. Cortes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 900.
https://doi.org/10.1182/blood.V130.Suppl_1.900.900
Published: 2017
Journal Articles

Alterations in Mesenchymal Stromal Precursor Cells in Patients with Chronic Myeloid Leukemia at the Onset of the Disease and During Treatment By Tyrosine Kinase Inhibitors

Free
Nataliya Petinati, PhD MD, Irina Shipounova, PhD, Alexey Bigildeev, PhD, Natalia Sats, PhD, Tamara Sorokina, MD, Ekaterina Chelysheva, MDPhD, Oleg Shukhov, MDPhD, Anna Petrova, MD, Anna G Turkina, Prof., MD, Nina Drize, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5242.
https://doi.org/10.1182/blood.V130.Suppl_1.5242.5242
Published: 2017
Journal Articles

The Analysis of 12-Year Overall Survival in Non-Selected Patients with Chronic Myeloid Leukemia with Tyrosinekinase Inhibitors Therapy in Routine Practice

Free
Lyudmila Vysotskaya, Tatiana Mitina, Elena Trifonova, MD PhD, Yulia Chernykh, Sergei Zakharov, Kirill Belousov, Elena Klinushkina, Elena Kataeva, MD, Anna G Turkina, Prof., MD, Anatoly Golenkov, MDProf
Journal: Blood
Blood (2017) 130 (Supplement 1): 5261.
https://doi.org/10.1182/blood.V130.Suppl_1.5261.5261
Published: 2017